Drugplain

Vixa Skineal .25 mg/g

Vixa Skineal Compound ketoconazole · CREAM · Yunnan Yuyao Bio-pharmaceutical Co.,Ltd.

No Recall History
Plain English

Vixa Skineal is a topical cream containing ketoconazole, an antifungal medication used to treat fungal skin infections. It works by stopping the growth of fungi on the skin.

Key Facts

Brand Name
Vixa Skineal
Generic Name
Vixa Skineal Compound ketoconazole
NDC Code (Product)
84659-9040
Manufacturer
Yunnan Yuyao Bio-pharmaceutical Co.,Ltd.
Strength
.25 mg/g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Drug Class
Azole Antifungal [EPC]
Marketing Start
06/01/2024

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Dosage & Administration

DOSAGE AND ADMINISTRATION: Apply externally to affected area twice daily. It is suggested to use for 2 weeks on ordinary tinea corporis and tinea cruris, for 4 weeks on tinea pedis and tinea manus. SIDE EFFECTS: VIXA SKINEAL has few side effects when used topically. A few instance of irritation or burning sensation may be observed occasionally during the treatment. But usually, it is unnecessary to stop the drug. CONTRAINDICATION:

Frequently Asked Questions

What is Vixa Skineal used for?

Vixa Skineal is a topical cream containing ketoconazole, an antifungal medication used to treat fungal skin infections. It works by stopping the growth of fungi on the skin.

Is Vixa Skineal a controlled substance?

Vixa Skineal is not classified as a controlled substance by the DEA.

What is the generic name for Vixa Skineal?

The generic name for Vixa Skineal is Vixa Skineal Compound ketoconazole. There are no other listed brand versions of Vixa Skineal Compound ketoconazole.

What is the NDC code for Vixa Skineal .25 mg/g?

The NDC (National Drug Code) for Vixa Skineal .25 mg/g is 84659-9040, listed by Yunnan Yuyao Bio-pharmaceutical Co.,Ltd..

Product NDC

84659-9040

Package NDC

84659-9040-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)